PodParley PodParley
PodParley
Symptom-based progression-free survival as a clinically relevant and patient-centric endpoint in chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the ALPINE trial episode artwork

EPISODE · Jan 7, 2026 · 2 MIN

Symptom-based progression-free survival as a clinically relevant and patient-centric endpoint in chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the ALPINE trial

from Medical Digest & Congress Report · host Medical Congress News

Jennifer R. Brown explains the results from the ALPINE trial at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:symptom-based-progression-free-survival-clinically-relevant-and-patient-centric-endpoint-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-results-alpine-trial

Episode metadata supplied by the publisher feed · Published Jan 7, 2026

Embed this episode

NOW PLAYING

Symptom-based progression-free survival as a clinically relevant and patient-centric endpoint in chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the ALPINE trial

0:00 2:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 2 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on January 7, 2026.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!